Ginger Treatment For Cancer-Related Nausea and VomitingName of the Trial
Phase II Randomized Study of Ginger in Patients With Cancer and Chemotherapy-Induced Nausea and Vomiting (CCUM-0201).
See the protocol summary.
Principal Investigator
Dr. Suzanna Zick, University of Michigan Integrative Medicine.
 |
Dr. Suzanna Zick
Principal Investigator |
Why This Trial Is Important
Nausea and vomiting are among the most distressing and feared side effects of cancer and cancer treatment. Beyond
being unpleasant, the nausea and vomiting associated with cancer and its treatment can lead to serious and
life-threatening complications, such as nutritional depletion, metabolic imbalance, esophageal damage, expulsion of oral
chemotherapy agents, and withdrawal from potentially curative treatment. Thus, effective treatment for nausea and
vomiting is critical to the care of cancer patients.
In this trial, researchers are testing the ability of two different doses (lower vs. higher) of the herb ginger to
treat delayed nausea and vomiting associated with chemotherapy. Ginger is believed to affect receptors in the digestive
tract for the neurotransmitter serotonin. This action is similar to conventional antinausea drugs.
“Ginger has been shown to be effective in a number of clinical trials against nausea and vomiting associated
with motion sickness, pregnancy, and postoperative recovery,” said Dr. Zick. “With this trial, we hope to
determine its efficacy and safety for chemotherapy-induced nausea and vomiting.
“We hope ginger will be effective for patients who continue to experience delayed nausea and vomiting despite
treatment with other antinausea drugs,” Dr. Zick added.
Contact Information
This clinical trial is no longer accepting new patients. To locate other supportive care clinical trials,
search the NCI database of clinical trials or call the NCI's Cancer
Information Service at 1-800-4-CANCER (1-800-422-6237). This call is completely confidential.
 Back to Top |
